Cytoplasmic Inclusions of Htt Exon1 Containing an Expanded Polyglutamine Tract Suppress Execution of Apoptosis in Sympathetic Neurons

Proteins containing extended polyglutamine repeats cause at least nine neurodegenerative disorders, but the mechanisms of disease-related neuronal death remain uncertain. We show that sympathetic neurons containing cytoplasmic inclusions formed by 97 glutamines expressed within human huntingtin exon1–enhanced green fluorescent protein (Q97) undergo a protracted form of nonapoptotic death that is insensitive to Bax deletion or caspase inhibition but is characterized by mitochondrial dysfunction. By treating the neurons with combined cytosine arabinoside and NGF withdrawal, we demonstrate that Q97 confers a powerful resistance to apoptosis at multiple levels: despite normal proapoptotic signaling (elevation of P-ser15–p53 and BimEL), there is no increase of Puma mRNA or Bax activation, both necessary for apoptosis. Even restoration of Bax translocation with overexpressed Puma does not activate apoptosis. We demonstrate that this robust inhibition of apoptosis is caused by Q97-mediated accumulation of Hsp70, which occurs through inhibition of proteasomal activity. Thus, apoptosis is reinstated by short hairpin RNA-mediated knockdown of Hsp70. These findings explain the rarity of apoptotic death in Q97-expressing neurons. Given the proteasomal blockade, we test whether enhancing lysosomal-mediated degradation with rapamycin reduces Q97 accumulation. Rapamycin reduces the amount of nonpathological Q25 by 70% over 3 d, but Q97 accumulation is unaffected. Interestingly, Q47 inclusions form more slowly as a result of constitutive lysosomal degradation, but faster-forming Q97 inclusions escape lysosomal control. Thus, cytoplasmic Q97 inclusions are refractory to clearance by proteasomal and lysosomal systems, leading to a toxicity that dominates over neuroprotective Hsp70. Our findings may explain the rarity of apoptosis but the inevitable cell death associated with polyQ inclusion diseases.

[1]  Martin Drozda,et al.  Inhibitors of Cytochrome c Release with Therapeutic Potential for Huntington's Disease , 2008, The Journal of Neuroscience.

[2]  A. Messer,et al.  Combinational approach of intrabody with enhanced Hsp70 expression addresses multiple pathologies in a fly model of Huntington's disease , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  M. Xilouri,et al.  A novel cell death pathway that is partially caspase dependent, but morphologically non‐apoptotic, elicited by proteasomal inhibition of rat sympathetic neurons , 2008, Journal of neurochemistry.

[4]  A. Tolkovsky,et al.  Rapamycin Inhibits Polyglutamine Aggregation Independently of Autophagy by Reducing Protein Synthesis , 2008, Molecular Pharmacology.

[5]  P. Verstreken,et al.  Suppression of Neurodegeneration and Increased Neurotransmission Caused by Expanded Full-Length Huntingtin Accumulating in the Cytoplasm , 2008, Neuron.

[6]  P. Boya,et al.  Intra-mitochondrial degradation of Tim23 curtails the survival of cells rescued from apoptosis by caspase inhibitors , 2008, Cell Death and Differentiation.

[7]  Suzanne Cory,et al.  Bcl-2-regulated apoptosis: mechanism and therapeutic potential. , 2007, Current opinion in immunology.

[8]  Y. B. Lee,et al.  Hsp70 suppresses apoptosis in sympathetic neurones by preventing the activation of c‐Jun , 2007, Journal of neurochemistry.

[9]  J. Lucas,et al.  BH3‐only proteins Bid and BimEL are differentially involved in neuronal dysfunction in mouse models of Huntington's disease , 2007, Journal of neuroscience research.

[10]  H. Zoghbi,et al.  Trinucleotide repeat disorders. , 2007, Annual review of neuroscience.

[11]  M. Deshmukh,et al.  Endoplasmic reticulum stress-induced apoptosis requires bax for commitment and Apaf-1 for execution in primary neurons , 2007, Cell Death and Differentiation.

[12]  A. Strasser,et al.  Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway , 2007, Oncogene.

[13]  J. Milbrandt,et al.  NGF augments the autophosphorylation of Ret via inhibition of ubiquitin‐dependent degradation , 2007, Journal of neurochemistry.

[14]  I. Kanazawa,et al.  The Induction Levels of Heat Shock Protein 70 Differentiate the Vulnerabilities to Mutant Huntingtin among Neuronal Subtypes , 2007, The Journal of Neuroscience.

[15]  K Dane Wittrup,et al.  Stochastic kinetics of intracellular huntingtin aggregate formation , 2006, Nature chemical biology.

[16]  A. Tolkovsky,et al.  The BH3‐only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons , 2006, Journal of neurochemistry.

[17]  I. Kanazawa,et al.  Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and p73 , 2006, The Journal of cell biology.

[18]  Stephen J. Morris,et al.  AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70. , 2006, Chemistry & biology.

[19]  R. Vabulas,et al.  Protein Synthesis upon Acute Nutrient Restriction Relies on Proteasome Function , 2005, Science.

[20]  R. Kopito,et al.  HDAC6 and Microtubules Are Required for Autophagic Degradation of Aggregated Huntingtin* , 2005, Journal of Biological Chemistry.

[21]  B. Harper Huntington Disease , 2005, Journal of the Royal Society of Medicine.

[22]  D. D. Mosser,et al.  Hsp70 Inhibits Heat-induced Apoptosis Upstream of Mitochondria by Preventing Bax Translocation* , 2005, Journal of Biological Chemistry.

[23]  K. Heidenreich,et al.  Proteasome inhibition elicits a biphasic effect on neuronal apoptosis via differential regulation of pro-survival and pro-apoptotic transcription factors , 2005, Molecular and Cellular Neuroscience.

[24]  Atsushi Iwata,et al.  Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Elaine H. J. Yew,et al.  Proteasome inhibition by lactacystin in primary neuronal cells induces both potentially neuroprotective and pro‐apoptotic transcriptional responses: a microarray analysis , 2005, Journal of neurochemistry.

[26]  E. Wagner,et al.  The limited role of NH2-terminal c-Jun phosphorylation in neuronal apoptosis , 2005, The Journal of cell biology.

[27]  S. Snyder,et al.  p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.

[28]  S. Cook,et al.  Regulatory phosphorylation of Bim: sorting out the ERK from the JNK , 2005, Cell Death and Differentiation.

[29]  R. Randall,et al.  BH3-only proteins: key regulators of neuronal apoptosis , 2005, Cell Death and Differentiation.

[30]  T. Koike,et al.  Early apoptotic and late necrotic components associated with altered Ca2+ homeostasis in a peptide‐delivery model of polyglutamine‐induced neuronal death , 2005, Journal of neuroscience research.

[31]  T. Ueno,et al.  Lysosomal Turnover, but Not a Cellular Level, of Endogenous LC3 is a Marker for Autophagy , 2005, Autophagy.

[32]  R. Llinás,et al.  Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[33]  E. Bennett,et al.  Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. , 2005, Molecular cell.

[34]  J. Caboche,et al.  Expanded huntingtin activates the C-JUN N TERMINAL KINASE/C-JUN pathway prior to aggregate formation in striatal neurons in culture , 2004, Neuroscience.

[35]  C. Horbinski,et al.  Proteasome inhibitors suppress formation of polyglutamine‐induced nuclear inclusions in cultured postmitotic neurons , 2004, Journal of neurochemistry.

[36]  Leonidas Stefanis,et al.  Application of proteasomal inhibitors to mouse sympathetic neurons activates the intrinsic apoptotic pathway , 2004, Journal of neurochemistry.

[37]  Eugene M. Johnson,et al.  Nerve Growth Factor Promotes the Survival of Sympathetic Neurons through the Cooperative Function of the Protein Kinase C and Phosphatidylinositol 3-Kinase Pathways* , 2004, Journal of Biological Chemistry.

[38]  L. Raymond,et al.  Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease , 2004, Molecular and Cellular Neuroscience.

[39]  K. Walsh,et al.  Heat Shock Protein 70 Participates in the Neuroprotective Response to Intracellularly Expressed β-Amyloid in Neurons , 2004, The Journal of Neuroscience.

[40]  J. Franklin,et al.  Bax, reactive oxygen, and cytochrome c release in neuronal apoptosis. , 2003, Antioxidants & redox signaling.

[41]  Fumiaki Tanaka,et al.  Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. , 2003, Human molecular genetics.

[42]  L. Greene,et al.  Nerve Growth Factor (NGF) Down-regulates the Bcl-2 Homology 3 (BH3) Domain-only Protein Bim and Suppresses Its Proapoptotic Activity by Phosphorylation* , 2002, The Journal of Biological Chemistry.

[43]  F. Hartl,et al.  Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Eugene M. Johnson,et al.  Cyclosporin A inhibits caspase-independent death of NGF-deprived sympathetic neurons , 2002, The Journal of cell biology.

[45]  Cheng Song,et al.  Expression of Full-length Polyglutamine-expanded Huntingtin Disrupts Growth Factor Receptor Signaling in Rat Pheochromocytoma (PC12) Cells* , 2002, The Journal of Biological Chemistry.

[46]  D. Sulzer,et al.  Proteasomal inhibition leads to formation of ubiquitin/α‐synuclein‐immunoreactive inclusions in PC12 cells , 2001, Journal of neurochemistry.

[47]  E A Zemskov,et al.  Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. , 2001, Human molecular genetics.

[48]  F. Gage,et al.  Identities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression , 2001, The Journal of cell biology.

[49]  A. Tolkovsky,et al.  Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis , 2001, Current Biology.

[50]  O. Bernard,et al.  Dominant-Negative c-Jun Promotes Neuronal Survival by Reducing BIM Expression and Inhibiting Mitochondrial Cytochrome c Release , 2001, Neuron.

[51]  I. Kanazawa,et al.  Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates. , 2000, Biochemical and biophysical research communications.

[52]  J. Ham,et al.  c-Jun and the transcriptional control of neuronal apoptosis. , 2000, Biochemical pharmacology.

[53]  Eugene M. Johnson,et al.  Phosphatidylinositol 3-Kinase Is Required for the Trophic, But Not the Survival-Promoting, Actions of NGF on Sympathetic Neurons , 2000, The Journal of Neuroscience.

[54]  Dick D. Mosser,et al.  Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome , 2000, Nature Cell Biology.

[55]  Emad S. Alnemri,et al.  Negative regulation of the Apaf-1 apoptosome by Hsp70 , 2000, Nature Cell Biology.

[56]  S. W. Davies,et al.  Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  S. Hersch,et al.  Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease , 2000, Nature Medicine.

[58]  T. Cotter,et al.  Heat shock protein 70 inhibits caspase-dependent and -independent apoptosis in Jurkat T cells. , 2000, Experimental cell research.

[59]  D. Rubinsztein,et al.  Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Housman,et al.  Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Eugene M. Johnson,et al.  BAX Translocation Is a Critical Event in Neuronal Apoptosis: Regulation by Neuroprotectants, BCL-2, and Caspases , 1999, The Journal of Neuroscience.

[62]  R. Heumann,et al.  Nerve growth factor-induced PKB/Akt activity is sustained by phosphoinositide 3-kinase dependent and independent signals in sympathetic neurons , 1999, Brain Research.

[63]  S. W. Davies,et al.  Transgenic models of Huntington's disease. , 1999, Human molecular genetics.

[64]  J. Penney,et al.  Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease , 1999, Nature.

[65]  J. Blenis,et al.  Caspase-8 Is Required for Cell Death Induced by Expanded Polyglutamine Repeats , 1999, Neuron.

[66]  A. Tolkovsky,et al.  A Role for MAPK/ERK in Sympathetic Neuron Survival: Protection against a p53-Dependent, JNK-Independent Induction of Apoptosis by Cytosine Arabinoside , 1999, The Journal of Neuroscience.

[67]  K. Moulder,et al.  Generation of Neuronal Intranuclear Inclusions by Polyglutamine-GFP: Analysis of Inclusion Clearance and Toxicity as a Function of Polyglutamine Length , 1999, The Journal of Neuroscience.

[68]  R. Kopito,et al.  Aggresomes: A Cellular Response to Misfolded Proteins , 1998, The Journal of cell biology.

[69]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[70]  J. Franklin,et al.  Control of Neuronal Size Homeostasis by Trophic Factor–mediated Coupling of Protein Degradation to Protein Synthesis , 1998, The Journal of cell biology.

[71]  Iris Salecker,et al.  Polyglutamine-Expanded Human Huntingtin Transgenes Induce Degeneration of Drosophila Photoreceptor Neurons , 1998, Neuron.

[72]  Michael R. Hayden,et al.  The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity , 1998, The Journal of cell biology.

[73]  A. Hackam,et al.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates , 1998, Nature Genetics.

[74]  S. Budd,et al.  Mitochondrial membrane potential and hydroethidine‐monitored superoxide generation in cultured cerebellar granule cells , 1997, FEBS letters.

[75]  L. Bourget,et al.  Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis , 1997, Molecular and cellular biology.

[76]  Andrew J. Bannister,et al.  Comparison Between the Timing of JNK activation, c‐Jun Phosphorylation, and Onset of Death Commitment in Sympathetic Neurones , 1997, Journal of neurochemistry.

[77]  Z. Ronai,et al.  Phosphorylation-dependent targeting of c-Jun ubiquitination by Jun N-kinase. , 1996, Oncogene.

[78]  S. Korsmeyer,et al.  BAX Is Required for Neuronal Death after Trophic Factor Deprivation and during Development , 1996, Neuron.

[79]  J. Martinou,et al.  Involvement of the proteasome in the programmed cell death of NGF‐deprived sympathetic neurons. , 1996, The EMBO journal.

[80]  John Calvin Reed,et al.  Antisense oligodeoxynucleotides to bax mRNA promote survival of rat sympathetic neurons in culture , 1996, Journal of neuroscience research.

[81]  M. Pariat,et al.  Ubiquitinylation is not an absolute requirement for degradation of c- Jun protein by the 26 S proteasome , 1995, The Journal of Biological Chemistry.

[82]  C. Nobes,et al.  Neutralizing Anti‐p21ras Fabs Suppress Rat Sympathetic Neuron Survival Induced by NGF, LIF, CNTF and cAMP , 1995, The European journal of neuroscience.

[83]  C. Nobes,et al.  Nerve Growth Factor is Required for Induction of c‐Fos Immunoreactivity by Serum, Depolarization, Cyclic AMP or Trauma in Cultured Rat Sympathetic Neurons , 1991, The European journal of neuroscience.

[84]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[85]  D. Rubinsztein,et al.  Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. , 2006, Current topics in developmental biology.

[86]  A. Goldberg,et al.  Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. , 2005, Methods in enzymology.

[87]  R. Llinás,et al.  Disturbed Ca 2 signaling and apoptosis of medium spiny neurons in Huntington ’ s disease , 2005 .

[88]  E. Wagner,et al.  The limited role of NH 2 -terminal c-Jun phosphorylation in neuronal apoptosis: Identification of the nuclear pore complex as a potential target of the JNK pathway , 2005 .

[89]  E. Johnson,et al.  ‘Men are but worms:’⋆ neuronal cell death in C. elegans and vertebrates , 2004, Cell Death and Differentiation.

[90]  D. Green,et al.  Stress management - heat shock protein-70 and the regulation of apoptosis. , 2001, Trends in cell biology.

[91]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[92]  K. Altendorf,et al.  Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases. , 1997, The Journal of experimental biology.

[93]  E. Hawrot,et al.  Long-term culture of dissociated sympathetic neurons. , 1979, Methods in enzymology.